BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24513799)

  • 1. Histologic grading of canine mast cell tumor: is 2 better than 3?
    Sabattini S; Scarpa F; Berlato D; Bettini G
    Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
    Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
    J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
    Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
    Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
    Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
    J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
    Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
    Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
    Moore AS; Frimberger AE; Taylor D; Sullivan N
    Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior.
    Kiupel M; Webster JD; Bailey KL; Best S; DeLay J; Detrisac CJ; Fitzgerald SD; Gamble D; Ginn PE; Goldschmidt MH; Hendrick MJ; Howerth EW; Janovitz EB; Langohr I; Lenz SD; Lipscomb TP; Miller MA; Misdorp W; Moroff S; Mullaney TP; Neyens I; O'Toole D; Ramos-Vara J; Scase TJ; Schulman FY; Sledge D; Smedley RC; Smith K; W Snyder P; Southorn E; Stedman NL; Steficek BA; Stromberg PC; Valli VE; Weisbrode SE; Yager J; Heller J; Miller R
    Vet Pathol; 2011 Jan; 48(1):147-55. PubMed ID: 21062911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens.
    Hergt F; von Bomhard W; Kent MS; Hirschberger J
    Vet Clin Pathol; 2016 Sep; 45(3):477-83. PubMed ID: 27483044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
    Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
    Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference.
    Northrup NC; Howerth EW; Harmon BG; Brown CA; Carmicheal KP; Garcia AP; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Gieger TL
    J Vet Diagn Invest; 2005 Nov; 17(6):561-4. PubMed ID: 16475514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
    Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
    Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
    Northrup NC; Harmon BG; Gieger TL; Brown CA; Carmichael KP; Garcia A; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Cheng AL; Howerth EW
    J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
    J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
    Berlato D; Murphy S; Laberke S; Rasotto R
    Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010-2013).
    Risselada M; Mathews KG; Griffith E
    J Am Vet Med Assoc; 2015 Jul; 247(2):184-9. PubMed ID: 26133218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.
    Martins AL; Carvalho FF; Mesquita JR; Gärtner F; Amorim I
    Open Vet J; 2021; 11(4):619-634. PubMed ID: 35070857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.
    Schlieben P; Meyer A; Weise C; Bondzio A; Einspanier R; Gruber AD; Klopfleisch R
    Vet J; 2012 Nov; 194(2):210-4. PubMed ID: 22578690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
    J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
    Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
    Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.